Developer docs
API playgroundTry for free, no card

Search company profiles

ARCHES

Full company profile

uuid0005xp5

Namestring
ARCHES
Legal namestring
ARCHES Technology
Websiteurl
arches.health
Company typeenum
Private
Founded yearint
2008
Descriptiontext

ARCHES Technology is a private, founder-led healthcare-technology company headquartered in New York that builds HIPAA- and SOC 2 Type 2-compliant patient engagement and marketing cloud software for oncology providers, health systems, and life-science companies. Its core platform, Keystone, is described as a HIPAA-compliant marketing cloud with deep EHR integration, multi-channel deployment (SMS, email, web, social), segmentation and profiling, A/B asset testing, multi-partner integration, and a 24/7 analytics portal. Built on top of Keystone, MyCareCompass is a digital oncology education module that integrates with provider EHR systems to deliver just-in-time, treatment-specific content to cancer patients across infusion chemotherapy, immunotherapy, oral chemotherapy, surgery, and radiation care pathways, supported by an oncology-focused psycho-social content library.

ARCHES monetizes through annual subscription-based SaaS licensing of Keystone and MyCareCompass to healthcare organizations and cancer centers, with quote-based enterprise pricing and direct enterprise sales, complemented by co-branding and sponsorship arrangements with pharmaceutical and life-science companies that want exposure within MyCareCompass. Documented enterprise healthcare-provider customers include Kettering Health Network (since 2018, expanded to immunotherapy in 2019 with a multi-module roadmap) and Fox Chase Cancer Center (since 2021), while the life-science client roster spans Genentech, Novartis Oncology, Sanofi, Gilead, Astellas, Takeda, GSK and others, and the company reports more than 2.5 million patients engaged through the platform. Leadership is concentrated in founder/CEO Daniella Koren and President Patrick Flavin; the company is bootstrapped with no disclosed funding rounds, operates a small team (11–50 employees), and supports a content-led go-to-market via PR, industry conferences, academic publication, and thought leadership.

Short descriptiontext

ARCHES Technology is a New York-based, HIPAA- and SOC 2-compliant healthcare SaaS company that licenses its Keystone marketing cloud and MyCareCompass oncology patient-engagement module to cancer centers, health systems, and life-science sponsors via annual enterprise contracts and direct sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient engagement software, oncology patient education, HIPAA marketing cloud, EHR-integrated healthcare SaaS, digital care navigation
Industry3 codes
1Care Navigation, Referral & Digital Front Door Platforms
CodeHLALABAHPrimaryYes
2Patient Portals & Self-Service Access
CodeHLACAEAAPrimaryNo
3Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling)
CodeHLACAPAMPrimaryNo
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Healthcare Patient Engagement Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Platform Licensing (Keystone)
TypeSubscription Recurring
Description

SaaS licensing of the Keystone HIPAA compliant marketing cloud platform to healthcare providers and life science companies. Platform licensing includes deployment, configuration, and ongoing support services.

arches.health
2MyCareCompass Licensing
TypeSubscription Recurring
Description

Digital patient engagement system licensing to oncology providers, cancer centers, and healthcare organizations. Includes EHR integration and ongoing content delivery services.

arches.health
3Co-branding and Sponsorship
TypeLicensing Royalties
Description

Co-branding and sponsorship opportunities for life sciences and healthcare companies within the MyCareCompass program to increase patient exposure to their cancer support services and resources.

arches.health
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Enterprise licensing for healthcare organizations
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for healthcare organizations and cancer centers

arches.health
2Life sciences sponsorship and co-branding
ModelSubscriptionBilling cadenceAnnual
Notes

Co-branding and sponsorship opportunities for pharmaceutical and healthcare companies

arches.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Keystone
Description

HIPAA compliant marketing cloud software platform designed specifically to support life science companies and healthcare providers. Key capabilities include responsive relationship marketing, deep segmentation/profiling capabilities, data driven tailoring of content, A/B asset testing, peer to peer community/network facilitation, multi partner integration, and 24/7 analytics portal.

arches.health
+1 more record
Core offering1 text field

ARCHES develops and licenses the Keystone HIPAA-compliant marketing cloud platform, which life science companies and healthcare providers use to run personalized, multi-channel patient communications with segmentation, A/B testing, and 24/7 analytics. On top of Keystone, it offers the MyCareCompass module, which integrates with provider EHR systems to deliver just-in-time oncology patient education across the treatment journey (infusion chemotherapy, immunotherapy, oral chemotherapy, surgery, and radiation).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 2.5 million patients engaged through the platform
+2 more records
Product overview1 text field

ARCHES offers a platform-plus-module architecture built around its core Keystone marketing cloud product and the MyCareCompass patient engagement module. Keystone serves as the HIPAA-compliant foundation for life science companies and healthcare providers, offering responsive relationship marketing, segmentation, content management, and analytics. MyCareCompass is the patient-facing digital oncology education program that integrates with provider EHR systems to deliver personalized, time-sensitive content to patients throughout their cancer treatment journey, including support for infusion chemotherapy, immunotherapy, and planned expansion to oral chemotherapy, surgery, and radiation.

Product and service2 records
1Keystone
CategoryMarketing Cloud Platform
2MyCareCompass
CategoryOncology Patient Engagement Module
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-26
Description

MyCareCompass launched at Fox Chase Cancer Center as result of the Astellas C3 Prize for Oncology Innovation. Platform delivers patient education at the right time throughout the cancer treatment journey.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-10-28
Description

Won the 2019 Astellas Oncology C3 Innovation Prize Grand Prize, receiving $200,000 in grants and resources. The C3 Prize funds innovative non-medical solutions to improve cancer care. Partnership includes continued collaboration on oncology patient education initiatives.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Partnership launched in 2018 with MyCareCompass at Kettering Health Network oncology service line. Initially focused on infusion chemotherapy patients, expanded to include immunotherapy module. Future plans include oral chemotherapy, surgery, and radiation modules. Partnership involves presenting engagement data at international conferences and ongoing program development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ARCHES

Healthcare Patient Engagement Softwarearches.health

ARCHES Technology is a New York-based, HIPAA- and SOC 2-compliant healthcare SaaS company that licenses its Keystone marketing cloud and MyCareCompass oncology patient-engagement module to cancer centers, health systems, and life-science sponsors via annual enterprise contracts and direct sales.

What ARCHES does

ARCHES Technology is a private, founder-led healthcare-technology company headquartered in New York that builds HIPAA- and SOC 2 Type 2-compliant patient engagement and marketing cloud software for oncology providers, health systems, and life-science companies. Its core platform, Keystone, is described as a HIPAA-compliant marketing cloud with deep EHR integration, multi-channel deployment (SMS, email, web, social), segmentation and profiling, A/B asset testing, multi-partner integration, and a 24/7 analytics portal. Built on top of Keystone, MyCareCompass is a digital oncology education module that integrates with provider EHR systems to deliver just-in-time, treatment-specific content to cancer patients across infusion chemotherapy, immunotherapy, oral chemotherapy, surgery, and radiation care pathways, supported by an oncology-focused psycho-social content library.

ARCHES monetizes through annual subscription-based SaaS licensing of Keystone and MyCareCompass to healthcare organizations and cancer centers, with quote-based enterprise pricing and direct enterprise sales, complemented by co-branding and sponsorship arrangements with pharmaceutical and life-science companies that want exposure within MyCareCompass. Documented enterprise healthcare-provider customers include Kettering Health Network (since 2018, expanded to immunotherapy in 2019 with a multi-module roadmap) and Fox Chase Cancer Center (since 2021), while the life-science client roster spans Genentech, Novartis Oncology, Sanofi, Gilead, Astellas, Takeda, GSK and others, and the company reports more than 2.5 million patients engaged through the platform. Leadership is concentrated in founder/CEO Daniella Koren and President Patrick Flavin; the company is bootstrapped with no disclosed funding rounds, operates a small team (11–50 employees), and supports a content-led go-to-market via PR, industry conferences, academic publication, and thought leadership.

ARCHES firmographics

Firmographics
Name
ARCHES
Legal name
ARCHES Technology
Website
https://arches.health
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
ARCHES Technology is a New York-based, HIPAA- and SOC 2-compliant healthcare SaaS company that licenses its Keystone marketing cloud and MyCareCompass oncology patient-engagement module to cancer centers, health systems, and life-science sponsors via annual enterprise contracts and direct sales.
Ownership category
akta.pro rank

ARCHES industry classification

Industry
Product category
Healthcare Patient Engagement Software
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro primary industry
Care Navigation, Referral & Digital Front Door Platforms (HLALABAH)
akta.pro secondary industries
Patient Portals & Self-Service Access (HLACAEAA), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM)

Keywords

  • Patient engagement software
  • Oncology patient education
  • HIPAA marketing cloud
  • EHR-integrated healthcare SaaS
  • Digital care navigation

Where ARCHES is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ARCHES business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Software Platform Licensing (Keystone): SaaS licensing of the Keystone HIPAA compliant marketing cloud platform to healthcare providers and life science companies. Platform licensing includes deployment, configuration, and ongoing support services.
  2. MyCareCompass Licensing: Digital patient engagement system licensing to oncology providers, cancer centers, and healthcare organizations. Includes EHR integration and ongoing content delivery services.
  3. Co-branding and Sponsorship: Co-branding and sponsorship opportunities for life sciences and healthcare companies within the MyCareCompass program to increase patient exposure to their cancer support services and resources.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing for healthcare organizations
SubscriptionAnnualLife sciences sponsorship and co-branding

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

ARCHES product offering

Product offering

Core offering

ARCHES develops and licenses the Keystone HIPAA-compliant marketing cloud platform, which life science companies and healthcare providers use to run personalized, multi-channel patient communications with segmentation, A/B testing, and 24/7 analytics. On top of Keystone, it offers the MyCareCompass module, which integrates with provider EHR systems to deliver just-in-time oncology patient education across the treatment journey (infusion chemotherapy, immunotherapy, oral chemotherapy, surgery, and radiation).

Product overview

ARCHES offers a platform-plus-module architecture built around its core Keystone marketing cloud product and the MyCareCompass patient engagement module. Keystone serves as the HIPAA-compliant foundation for life science companies and healthcare providers, offering responsive relationship marketing, segmentation, content management, and analytics. MyCareCompass is the patient-facing digital oncology education program that integrates with provider EHR systems to deliver personalized, time-sensitive content to patients throughout their cancer treatment journey, including support for infusion chemotherapy, immunotherapy, and planned expansion to oral chemotherapy, surgery, and radiation.

Differentiator

Problem solved

Functional benefit

Brands

  • Keystone: HIPAA compliant marketing cloud software platform designed specifically to support life science companies and healthcare providers. Key capabilities include responsive relationship marketing, deep segmentation/profiling capabilities, data driven tailoring of content, A/B asset testing, peer to peer community/network facilitation, multi partner integration, and 24/7 analytics portal.
  • MyCareCompass

Products and services

  • Keystone
  • MyCareCompass

Quantifiable outcome

  • Over 2.5 million patients engaged through the platform
  • +2 more outcomes

Companies that use ARCHES

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

ARCHES technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

ARCHES partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Fox Chase Cancer CentercoreStrategic or Co-development Partner · 26 March 2021MyCareCompass launched at Fox Chase Cancer Center as result of the Astellas C3 Prize for Oncology Innovation. Platform delivers patient education at the right time throughout the cancer treatment journey.
  • Astellas OncologycoreStrategic or Co-development Partner · 28 October 2019Won the 2019 Astellas Oncology C3 Innovation Prize Grand Prize, receiving $200,000 in grants and resources. The C3 Prize funds innovative non-medical solutions to improve cancer care. Partnership includes continued collaboration on oncology patient education initiatives.
  • Kettering Health NetworkcoreStrategic or Co-development Partner · 1 January 2018Partnership launched in 2018 with MyCareCompass at Kettering Health Network oncology service line. Initially focused on infusion chemotherapy patients, expanded to include immunotherapy module. Future plans include oral chemotherapy, surgery, and radiation modules. Partnership involves presenting engagement data at international conferences and ongoing program development.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

ARCHES competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ARCHES social profiles

Digital presence

ARCHES compliance and trust

Trust signal

Compliance2 records

ARCHES financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ARCHES leadership team

Management profile

Number of profiles

Profiles2 records

ARCHES funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ARCHES M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARCHES

What does ARCHES do?

ARCHES develops and licenses the Keystone HIPAA-compliant marketing cloud platform, which life science companies and healthcare providers use to run personalized, multi-channel patient communications with segmentation, A/B testing, and 24/7 analytics. On top of Keystone, it offers the MyCareCompass module, which integrates with provider EHR systems to deliver just-in-time oncology patient education across the treatment journey (infusion chemotherapy, immunotherapy, oral chemotherapy, surgery, and radiation).

Is ARCHES a public or private company?

ARCHES is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ARCHES founded?

ARCHES was founded in 2008. It employs 11 to 50 people.

Where is ARCHES based?

ARCHES is headquartered in New York, United States, in the North America region.

How does ARCHES make money?

Three revenue lines are on record. Software Platform Licensing (Keystone) is the primary driver. The others are myCareCompass Licensing and co-branding and Sponsorship.

Does ARCHES have an API?

No public API is recorded for ARCHES.

What industry is ARCHES in?

ARCHES's product category is Healthcare Patient Engagement Software. Its primary akta.pro industry code is HLALABAH, Care Navigation, Referral & Digital Front Door Platforms, with a secondary code of HLACAEAA, Patient Portals & Self-Service Access. Its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
News Channel 3-12Attorney General sues Trump Administration over selective energy investment terminationsCalifornia Attorney General Rob Bonta is co-leading a coalition of 13 attorneys general in filing a federal lawsuit against the Trump Administration over its May 2025 DOE policy memorandum that subjected previously congressionally-approved energy and infrastructure projects to an opaque review process, resulting in the termination of billions in funding from the Infrastructure Investment and Jobs Act and Inflation Reduction Act. The suit argues the terminations violated the Impoundment Control Act of 1974 and the constitutional separation of powers, as only Congress has the authority to appropriate and rescind funding. Among the most affected projects is California's $1.2 billion ARCHES Hydrogen Hub, which was forced to lay off its entire staff and caused private equipment manufacturers and renewable energy companies to cancel investments, while California's Governor Gavin Newsom has vowed to continue the program independently.innovation.ca.govCalifornia files lawsuit against Trump for illegally terminating $1.2 billion in energy and infrastructure programsCalifornia filed a lawsuit against the Trump administration for unlawfully terminating $1.2 billion in energy and infrastructure funding, including programs like ARCHES and RECI, which threatened over 200,000 jobs and significant health savings. The lawsuit asserts the termination violated the constitutional separation of powers and was motivated by partisan retribution. The issue stems from the Trump administration's decision to cancel federally approved clean energy projects, including a $12.6 billion hydrogen hub in California.Business Wire BlogArches Massachusetts IPA and Valley Medical Group P.C. Announce Strategic Partnership, Strengthening the Physician-Led Value-Based Care Movement in MassachusettsArches Massachusetts IPA and Valley Medical Group P.C. announced a strategic partnership to strengthen physician-led value-based care in Massachusetts. This collaboration allows Valley Medical’s clinicians to retain ownership while accessing Arches’ contracting platform, performance analytics, and operational support for commercial and Medicare risk contracts. The move follows Arches' approval to join the Medicare Shared Savings Program starting January 1, 2026, positioning it as a key player in reducing total medical expenses through independent practice models.EenewsDOE funding cuts hit 223 blue state energy projectsThe U.S. Department of Energy terminated 321 financial awards totaling approximately $7.56 billion following a review led by Energy Secretary Chris Wright, citing alignment with administration priorities and taxpayer protection. The cancellations primarily affect renewable energy and hydrogen hub projects, including the ARCHES hub in California and another in the Pacific Northwest, which were selected under the previous administration. While the White House defended the cuts as fulfilling campaign promises to reduce spending, Democratic lawmakers condemned the move as politically motivated retaliation against blue states that would increase energy costs.PR NewswireArches Technology Appoints Seasoned Health Tech Executive Patrick Flavin as PresidentArches Technology appointed Patrick Flavin as its President to lead the company's continued growth and expand business opportunities in the health technology sector. Flavin brings over 20 years of industry experience, most recently serving as SVP of Life Sciences Business Development at Outcome Health. This leadership change aims to leverage his background in building life sciences companies to drive the consumerization of healthcare through patient empowerment.PR NewswireArches Technology Launches My Care Compass (MCC): A Digital Oncology Education Program for Patients Undergoing Infusion Chemotherapy at Kettering Health NetworkArches Technology has launched My Care Compass (MCC), a digital patient navigation tool developed in partnership with Kettering Health Network to educate and prepare oncology patients undergoing infusion chemotherapy. The platform delivers timed communications via animated videos, emails, and text messages, integrating directly with Kettering Health Network's Epic EMR system to automate patient-specific outreach without requiring manual data entry by hospital staff. The program will expand in 2018 to include content for patients undergoing immunotherapy and other cancer treatments.